Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26239888
DOI
10.1002/ijc.29712
Knihovny.cz E-zdroje
- Klíčová slova
- HPV, head and neck tumours, integration, prognosis, survival,
- MeSH
- dlaždicobuněčné karcinomy hlavy a krku MeSH
- infekce papilomavirem komplikace virologie MeSH
- integrace viru genetika MeSH
- lidé MeSH
- nádory hlavy a krku mortalita virologie MeSH
- prognóza MeSH
- proporcionální rizikové modely MeSH
- Southernův blotting MeSH
- spinocelulární karcinom virologie MeSH
- tonzilární nádory virologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Integration, which leads to the disruption of the circular HPV genome, is considered as a critical, albeit not obligatory, step in carcinogenic progression. Although cervical carcinomas with extrachromosomal HPV plasmid genomes have been described, the virus is integrated in 70% of HPV16-positive cervical tumours. Limited information is available about HPV integration in head and neck tumours (HNC). In this study, we have characterised the physical status of HPV in a set of tonsillar tumour samples using different methods--the mapping of E2 integration breakpoint at the mRNA level, the 3' RACE based Amplification of Papillomavirus Oncogene Transcripts (APOT) assay and Southern blot. Furthermore, the impact of HPV integration on patients' prognosis has been evaluated in a larger set of 186 patients with head and neck cancer. Based on the analysis of E2 mRNA, HPV was integrated in the host genome in 43% of the HPV-positive samples. Extrachromosomal or mixed form was present in 57%. In fresh frozen samples, the APOT and E2 mapping results were in agreement. The results were confirmed using Southern blotting. Furthermore, the type and exact site of integration were determined. The survival analysis of 186 patients revealed HPV positivity, tumour size and lymph node positivity as factors that influence disease specific survival. However, no statistically significant difference was found in disease specific survival between patients with HPV-positive integrated vs. extrachromosomal/mixed forms of the virus.
Department of Genetics and Microbiology Faculty of Science Charles University Prague Czech Republic
Department of Immunology Institute of Hematology and Blood Transfusion Prague Czech Republic
Veterans Affairs Healthcare System and Department of Pathology University of Iowa Iowa City IA
Citace poskytuje Crossref.org
PD1+CD8+ Cells Are an Independent Prognostic Marker in Patients with Head and Neck Cancer
The Present and Future of Virology in the Czech Republic-A New Phoenix Made of Ashes?
ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas
HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan